
Retractable Technologies RVP
€ 0.58
0.16%
Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025
Retractable Technologies DPO 2011-2026 | RVP
DPO Jährlich Retractable Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.6 | 59.2 | 73.5 | 71.9 | 86.5 | 66.1 | 85 | 73.8 | 83.8 | 110 | 83.4 | 91.1 | 82.8 | 60.3 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 110 | 48.6 | 76.8 |
DPO Vierteljährlich Retractable Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46.9 | 38 | 49.6 | - | 28 | 40.4 | 59 | - | 52.9 | 53.8 | 66.1 | - | 43.4 | 96.4 | 52.7 | - | 109 | 89 | 63.1 | - | 112 | 188 | 126 | 59.5 | 58 | 68.6 | 87 | 85 | 69.3 | 90.6 | 97.9 | - | 63.3 | 83.2 | 93.5 | - | 73.1 | 82.3 | 124 | - | 83.1 | 126 | 131 | - | 66.7 | 99.9 | 108 | - | 79.8 | 90.2 | 106 | - | 76.4 | 86.2 | 87.1 | - | 65.4 | 66 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 188 | 28 | 80.9 |
DPO anderer Aktien in der Medizinische Instrumente
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | ||
|
Baxter International
BAX
|
50.7 | $ 19.93 | 0.99 % | $ 10.2 B | ||
|
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | ||
|
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
73.7 | $ 8.71 | 3.75 % | $ 176 M | ||
|
Alcon
ALC
|
63.6 | $ 81.19 | 0.07 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
81.2 | $ 36.37 | -1.57 % | $ 1.71 B | ||
|
Repro Med Systems
KRMD
|
52 | $ 5.37 | -1.56 % | $ 245 M | ||
|
Haemonetics Corporation
HAE
|
41.9 | $ 65.87 | -0.15 % | $ 3.32 B | ||
|
electroCore
ECOR
|
279 | $ 6.83 | -3.73 % | $ 37.7 K | ||
|
AngioDynamics
ANGO
|
96.2 | $ 10.2 | 2.2 % | $ 417 M | ||
|
ICU Medical
ICUI
|
34.9 | $ 149.04 | -0.66 % | $ 3.63 B | ||
|
InfuSystem Holdings
INFU
|
62.5 | $ 8.14 | 1.12 % | $ 168 M | ||
|
The Cooper Companies
COO
|
72.6 | $ 80.95 | 0.72 % | $ 16.1 B | ||
|
Masimo Corporation
MASI
|
84.4 | $ 134.5 | -1.29 % | $ 7.17 B | ||
|
Harvard Bioscience
HBIO
|
47.4 | $ 0.5 | -7.06 % | $ 21.2 M | ||
|
Glaukos Corporation
GKOS
|
67.2 | $ 117.26 | -1.43 % | $ 5.68 B | ||
|
Merit Medical Systems
MMSI
|
34.4 | $ 80.09 | -0.19 % | $ 4.66 B | ||
|
OraSure Technologies
OSUR
|
36.6 | $ 2.78 | -0.54 % | $ 207 M | ||
|
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | ||
|
iRhythm Technologies
IRTC
|
12.6 | $ 150.09 | 0.74 % | $ 4.68 B | ||
|
LeMaitre Vascular
LMAT
|
14.5 | $ 84.08 | 0.26 % | $ 1.89 B | ||
|
Intuitive Surgical
ISRG
|
25.7 | $ 505.88 | -0.33 % | $ 180 B | ||
|
STERIS plc
STE
|
31.8 | $ 261.25 | -0.23 % | $ 25.8 B | ||
|
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | ||
|
Microbot Medical
MBOT
|
52.9 | $ 1.84 | -1.34 % | $ 18.8 M | ||
|
Nephros
NEPH
|
50.5 | $ 4.4 | 0.23 % | $ 45.7 M | ||
|
Utah Medical Products
UTMD
|
18 | $ 60.16 | -2.42 % | $ 218 M | ||
|
Milestone Scientific
MLSS
|
36.5 | $ 0.29 | -0.7 % | $ 23.1 M | ||
|
Envista Holdings Corporation
NVST
|
56.8 | $ 23.07 | -1.28 % | $ 3.97 B | ||
|
Pro-Dex
PDEX
|
35.4 | $ 38.84 | -1.43 % | $ 128 M | ||
|
Predictive Oncology
POAI
|
547 | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
68.4 | $ 13.69 | 0.48 % | $ 658 M | ||
|
Becton, Dickinson and Company
BDX
|
59.3 | $ 201.67 | 0.29 % | $ 58 B | ||
|
Repligen Corporation
RGEN
|
24.3 | $ 151.86 | -2.88 % | $ 8.46 M | ||
|
ResMed
RMD
|
34.9 | $ 251.52 | -2.37 % | $ 36.7 B | ||
|
BioLife Solutions
BLFS
|
130 | $ 22.08 | -2.21 % | $ 1.02 B | ||
|
Stereotaxis
STXS
|
99 | $ 2.26 | -3.21 % | $ 182 M | ||
|
STAAR Surgical Company
STAA
|
74.3 | $ 18.79 | -0.8 % | $ 923 M | ||
|
Teleflex Incorporated
TFX
|
37.1 | $ 105.0 | -0.43 % | $ 4.92 B | ||
|
West Pharmaceutical Services
WST
|
46.4 | $ 226.43 | -2.61 % | $ 16.5 B | ||
|
DENTSPLY SIRONA
XRAY
|
54.3 | $ 12.28 | 0.04 % | $ 2.5 B |